Hepatocellular cancer
- 1 June 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 19 (3) , 229-234
Abstract
The Milan criteria are still considered to be the best ones to select patients with hepatocellular cancer (HCC) for liver transplantation. Although the Milan criteria allowed lowering the incidence of tumor recurrence to a remarkable 10%, there is growing evidence that high numbers of patients were unrightfully excluded from a curative liver transplantation when exceeding these criteria. New strategies have been advocated during recent years with the intent not only to enlarge the number of potential transplant candidates, but also to select recipients with the lowest biological risk of recurrence. Different 'biological' and 'dynamic' parameters have been proposed both in western and eastern scenarios, such as α-fetoprotein dynamics, radiological response to locoregional treatments and several inflammatory markers, the neutrophil-to-lymphocyte ratio being the most promising one. The paradigm that HCC patients should be selected according to morphological aspects (tumor numbers and diameters) only, based on the almost 20-year old success story of the Milan criteria, should be modified by combining these parameters with newer biological tumor markers in order to further refine the selection for liver transplantation. Such therapeutic algorithm will allow to further improve selection for and thus outcome after liver transplantation for HCC patients.Keywords
This publication has 37 references indexed in Scilit:
- Moving past “One Size (and Number) Fits All” in the selection of candidates with hepatocellular carcinoma for liver transplantationLiver Transplantation, 2013
- Offer patterns of nationally placed livers by donation service areaLiver Transplantation, 2013
- Extended Postinterventional Tumor Necrosis—Implication for Outcome in Liver Transplant Patients with Advanced HCCPLOS ONE, 2013
- Prognostic Role of C-Reactive Protein in Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisInternational Journal of Medical Sciences, 2013
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent RecurrenceAmerican Journal of Transplantation, 2011
- The challenges of liver transplantation for hepatocellular carcinoma on cirrhosisTransplant International, 2010
- Liver transplantation and conventional surgery for advanced hepatocellular carcinomaTransplant International, 2010
- Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical FactorAmerican Journal of Transplantation, 2010
- The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteriaTransplant International, 2009